Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B6BE
|
|||
| Former ID |
DIB005063
|
|||
| Drug Name |
OT-417
|
|||
| Synonyms |
OT-417 (inhaled dry powder, cystic fibrosis); OT-417 (inhaled dry powder, cystic fibrosis), Oriel Therapeutics; OT-417 (inhaled dry powder, cystic fibrosis), Sandoz
Click to Show/Hide
|
|||
| Indication | Cystic fibrosis [ICD-11: CA25; ICD-10: E84, E84.9; ICD-9: 277] | Investigative | [1] | |
| Company |
Oriel Therapeutics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.